Dr Reddys Laboratories Ltd Share Price Today - Live Blog for May 06, 2026

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 3.05%. At this moment, it's actively trading at 1310.00, presenting an enticing opportunity for those in the market.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 4.23%, reaching the current market price of 1325.00. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 4.23% uptick in its share price. As a result, it's now actively trading at 1325.00 per share, making it an attractive option for investors.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 3.21% upswing and is currently trading at 1312.00, indicating strong market sentiment.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 3.21% uptick in its share price. As a result, it's now actively trading at 1312.00 per share, making it an attractive option for investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 1.88% boost, with the current market value at 1295.10 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's stock has surged by 1.88%, and it is currently trading at 1295.10. Additionally, the stock maintains a PE ratio of 19.2100, while the industry PE is 33.7519.

After a significant 0.94% gain, Dr Reddys Laboratories Ltd's shares are now valued at 1283.20 in the current market. This upward movement is attracting attention from both retail and institutional investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.94% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1283.20 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.94% uptick in its share price. As a result, it's now actively trading at 1283.20 per share, making it an attractive option for investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.94% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1283.20 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.